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E-mailAbstract—Therapeuticmicrobubbles couldmake an important contribution to the diagnosis and treatment of can-
cer. Acoustic characterisation was performed on microfluidic generated microbubble populations that either were
bare or had liposomes attached. Through the use of broadband attenuation techniques (3–8MHz), the shell stiffness
wasmeasured to be 0.72 ± 0.01 and 0.78 ± 0.05 N/m and shell friction was 0.37 ± 0.05 and 0.74 ± 0.053 1026 kg/s for
bare and liposome-loadedmicrobubbles, respectively.Acoustic scatter revealed that liposome-loadedmicrobubbles
had a lower subharmonic threshold, occurring from a peak negative pressure of 50 kPa, comparedwith 200 kPa for
equivalent bare microbubbles. It was found that liposome loading had a negligible effect on the destruction
threshold for this microbubble type, because at a mechanical index .0.4 (570 kPa), 80% of both populations
were destroyed. (E-mail: j.r.mclaughlan@leeds.ac.uk)  2016 The Authors. Published by Elsevier Inc. on behalf
of World Federation for Ultrasound in Medicine & Biology. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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Microbubbles.INTRODUCTION
Phospholipid-encapsulated microbubbles are routinely
used as contrast agents for diagnostic ultrasound imaging
because of their acoustic impedance mismatch with blood
and their highly compressible nature in response to an ul-
trasound field (Claudon et al. 2013; Cosgrove 2006;
Forsberg et al. 1998). Maximum scatter of an
ultrasound wave by microbubbles occurs when the
frequency of these waves is equal to the resonance
frequency of the microbubbles. The size of
encapsulated microbubbles is a key factor in their
resonant frequency, and most commercial contrast
agents (1–10 mm) have resonances within the range of
frequencies used for diagnostic ultrasound imaging
(Stride and Saffari 2003).
Microbubbles can undergo both linear and non-linear
oscillations depending on the amplitude of the appliedddress correspondence to: James R. McLaughlan, Electronic
ectrical Engineering, University of Leeds, Leeds, LS2 9JT, UK.
: j.r.mclaughlan@leeds.ac.uk
346acoustic field (Emmer et al. 2007). Contrast imaging
uses non-linearmicrobubble behaviour for a number of im-
aging techniques, such as pulse inversion, harmonic imag-
ing and power modulation (Burns et al. 1994; Schrope and
Newhouse 1993; Simpson et al. 1999). Coded excitation,
such as chirps, are techniques used to increase the
signal-to-noise ratio (SNR) for ultrasound imaging
(Misaridis and Jensen 2005) by increasing the transited en-
ergy without decreasing the axial resolution or increasing
the acoustic pressure. Longer-duration exposures can be
used to increase the non-linear behaviour of microbubbles
(Zhang et al. 2007), which can improve the contrast-to-
tissue ratio (CTR) for contrast imaging (Harput et al.
2013; Sun et al. 2007). The response of a microbubble to
an acoustic field depends on a number of factors, such as
the frequency of excitation, microbubble size and shell
composition (Sun et al. 2014). Generally, for low-
amplitude excitation, microbubbles will oscillate linearly
around their equilibrium radius, where the frequency con-
tent of the backscattered signal would be determined by
the excitation waveform. Increasing the amplitude of exci-
tation can result in non-linear oscillations of the
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mental drive frequency (f0) (de Jong et al. 2002). Superhar-
monics (nf0) and ultraharmonics (nf0/2) can be generated
by non-linear oscillations, which are used to enhance ultra-
sound contrast imaging (de Jong et al. 2009; Maresca et al.
2013). Second harmonic (2f0) emissions from
microbubbles have been reported to improve the
resolution of contrast-enhanced ultrasound imaging
(Forsberg et al. 1997). Nevertheless, because of non-
linear propagation of the ultrasound wave (Leighton
2007), a second harmonic component can be generated
in tissue, which can also be used for imaging (Tranquart
et al. 1999), but can reduce the performance of contrast im-
aging (Goertz et al. 2005; Tang et al. 2010; Yildiz et al.
2015). As subharmonic (f0/2) emissions are unique to
microbubble activity, they can be used to improve the
CTR (Goertz et al. 2007; Shankar et al. 1998). However,
it has been found that the CTR can be reduced in the
region beyond a microbubble population because of the
generation of the non-linear harmonics by the microbub-
bles that then propagate into the tissue (Tang et al.
2010). At higher acoustic amplitudes, other microbubble
phenomena may occur, such as surface mode oscillations
(Dollet et al. 2008) and lipid shedding. The latter could
have implications for drug delivery using microbubbles
(Borden et al. 2005). Further increases in the acoustic
amplitude can result in the rapid expansion and collapse
associated with inertial cavitation (Neppiras 1980;
Prentice et al. 2005) and the destruction of the
microbubble. In addition to the generation of non-linear
harmonics, high-amplitude excitation can result in the gen-
eration of broadband emissions that can also be used for ul-
trasound contrast imaging (Gessner et al. 2010; Kruse and
Ferrara 2005).
The Rayleigh–Plesset–Noltingk–Neppiras–Poritsky
(RPNNP) equation is commonly used to simulate the dy-
namics of a free gas bubble in a liquid medium (Neppiras
and Noltingk 1951; Noltingk and Neppiras 1950; Plesset
1949; Poritsky 1951; Rayleigh 1917). This equation,
including its limitations (Leighton 1994), forms the basis
for most theoretical models of encapsulated microbub-
bles (Doinikov and Bouakaz 2011). A commonly used
modification of this equation for phospholipid-shelled
microbubbles is the Marmottant model (Marmottant
et al. 2005). This model introduces a term for effective
surface tension that is dependent on the instantaneous mi-
crobubble radius, which results in three regimes for shell
motion: buckled, elastic and ruptured. A consequence of
this modification is the ability to then simulate large-
amplitude oscillations, which can lead to non-linear
behaviour in the microbubble. Such an effect has been
predicted by this model and observed using high-speed
imaging (de Jong et al. 2007); it is ‘‘compression-only’’
behaviour, which is when a microbubble, typically in abuckled state, undergoes compression in response to an
ultrasound field, but very limited expansion. These non-
linear oscillations can give rise to harmonic emissions
from microbubbles at low acoustic pressures (Sijl et al.
2011). Subharmonic emissions generated by non-linear
oscillations of phospholipid-encapsulated microbubbles
are used for in vivo and clinical applications of diagnostic
ultrasound imaging (Eisenbrey et al. 2015). These emis-
sions required a threshold acoustic pressure to be ex-
ceeded to be generated, which is true for both free gas
bubbles (Prosperetti 1976) and coated microbubbles
(Sijl et al. 2010). Prosperetti described a general deriva-
tion for the acoustic pressure thresholds required for sub-
harmonic components to be present in the acoustic
emissions generated from acoustically driven gas bub-
bles, applied to coated bubbles (Prosperetti 2013). In
this derivation it is noted that the subharmonic threshold
can be lowered when compared with that of an uncoated
bubble, because of the presence of discontinuities or near
discontinuities in the shell of the microbubble, such as
buckling.
The therapeutic application of ultrasound for cancer
therapy has been widely investigated (Wood and Sehgal
2015), and the use of therapeutic microbubbles that can
be targeted to specific cancerous cells holds particular
promise for diagnosis and therapy (Klibanov and
Hossack 2015). A common approach for the loading of
therapeutics onto amicrobubble is through the attachment
of drug-filled liposomes to the shell of a microbubble
(Geers et al. 2011; Kheirolomoom et al. 2007;
Lentacker et al. 2010; Peyman et al. 2012). The
ultrasonic release of a therapeutic payload from a
microbubble can be achieved through its destruction
(Christiansen et al. 2003; Ferrara et al. 2007; Korpanty
et al. 2005; Lindner 2004; Mayer et al. 2008; Schlegel
et al. 2016; Zhu et al. 2015) or through a controlled
release mechanism such as phospholipid shedding
(Luan et al. 2014). Nevertheless, should the microbubbles
or free gas bubbles (generated from microbubble rupture)
(de Jong et al. 2002; Postema et al. 2005) emit and/or re-
radiate acoustic pressure in response to being driven by an
acoustic field during this process, this could help increase
target cell permeability through sonoporation, improving
the therapeutic outcome (Delalande et al. 2013; Greenleaf
et al. 1998;Kooiman et al. 2014;McLaughlan et al. 2013).
The aim of this study was to investigate the effect of
liposome loading on the acoustic response of microbub-
ble populations that were produced using a microfluidic
manufacturing process (Peyman et al. 2012). The micro-
bubble shell parameters, acoustic response and destruc-
tion thresholds were measured. In this article, the term
destruction refers to the fragmentation of the microbub-
ble and dissolution of the gas core (Christiansen et al.
2003; Ferrara et al. 2007).
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Microbubble and liposome manufacture
Liposomes were manufactured prior to microbubble
manufacture by repeatedly extruding a phospholipid so-
lution through a polycarbonate membrane (Olson et al.
1979). The phospholipids used in liposome manufacture
were prepared by mixing DSPC, cholesterol, DSPE–
PEG2000–Biotin (850365,700000 and 880129, Avanti
Polar Lipids, Alabaster, AL, USA) and DHPE–Oregon
Green (O-12650, Life Technologies, Paisley, UK) dis-
solved in chloroform, at 62.8, 32.3, 4.8 and 0.1 mol%,
respectively (Abou-Saleh et al. 2013). The chloroform
was evaporated under vacuum for 24 hours, after which
the lipids were re-suspended in a buffer containing
1 mg/mL propidium iodide (P4864, Sigma-Aldrich,
Dorset, UK), using a hot plate and vortex. However, for
the purposes of this study, the fluid content of the lipo-
somes was not important. The solution was then repeat-
edly passed through a mini-extruder (Avanti Polar
Lipids) that was heated to 60C to generate liposomes.
Un-encapsulated propidium iodide was removed by pass-
ing the liposome solution through a column (G-25, GE
Healthcare, Buckinghamshire, UK). This processFig. 1. (a) Schematic of the liposome-loaded microbubble (not
ages of a liposome-loaded microbubble population. (c, d) Hist
loaded microbubbles uproduced a final concentration of 1 3 1013 liposomes/
mL with a mean diameter of 200 nm.
The phospholipid solution used in microbubble pro-
duction was prepared by mixing DPPC (850355, Avanti
Polar Lipids) and DSPE–PEG2000–Biotin, which had
been dissolved in chloroform, at 95 and 5 mol% respec-
tively (Abou-Saleh et al. 2014). After evaporation of
the chloroform, the lipids were re-suspended with a saline
solution containing filtered water, 1% glycerol and 4 mg/
mL NaCl, in a 1-mL vial using an ultrasound bath. A so-
lution containing 13 1010 liposomes was incubated with
3 mL of NeutrAvidin (A2666, Life Technologies), a
biotin-binding protein, for 20 min. This solution was
then added to the 1-ml vial containing the phospholipid
solution, to be used for microbubble production and incu-
bated for an additional 20 min. This solution was then
combined with (C3F8) gas in a multiplexed microfluidic
manufacturing system for microbubble production
(Peyman et al. 2012, 2016). Figure 1(a) is a schematic
of the final liposome-loaded microbubble, whereas
Figure 1(b) contains both dark-field and fluorescence mi-
crographs of a microbubble population. For this example,
a green fluorescent lipid was incorporated into theto scale). (b) Dark-field and fluorescence microscopy im-
ograms of the size ranges for (c) bare and (d) liposome-
sed in this study.
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Fig. 3. Schematic of the apparatus used to measure the destruc-
tion threshold of microbubble populations, where the bright-
field microscopy images reveal bubbles before and after
destruction.
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bubble shell. The concentration and size distribution were
measured optically and gave a mean diameter of
1.7 6 1.2 mm for the liposome-loaded microbubbles
and 1.6 6 1.0 mm for the bare microbubbles (Fig. 1c,
d). An average total concentration of 6 3 108 6
3 3 108 microbubbles/mL, for both bare and liposome-
loaded microbubbles was measured through five repeat
preparations of each microbubble type (McLaughlan
et al. 2013).
Acoustic estimation of microbubble shell parameters
Figure 2(a) is a diagram of the experimental setup
used to measure the attenuation of a broadband ultra-
sound pulse, which propagated through an interaction
chamber containing populations of either bare or
liposome-loaded microbubbles. In both cases the total
concentration within this chamber did not exceed
2 3 106 microbubbles/mL. The interaction chamber
was an acrylic cylinder with an internal diameter of
30 mm; it had a total volume of 100 mL that was filled
with filtered and de-ionised water, which was replaced
between sample measurements. Three acoustic windows
were cut into the cylinder, 20 mm in diameter, to allow
direct propagation of the ultrasound beam and detection
at 90 (Fig. 2). Plastic wrap 12.5 mm thick was used to
seal these acoustic windows to ensure that the chamber
Fig. 4. Measured attenuation over the 3–8 MHz ranges of (a) bare and (b) liposome-loaded microbubbles. Error bars
represent standard deviations of five repeat measurements. (c) Calculated resonant frequency for the loaded and bare mi-
crobubbles using the shell parameters in Table 1. Inset: Expanded view of these values around the mean microbubble
diameter used in this study.
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sound beam. The size of the acoustic windows ensured
that the excitation pulse propagated without interactionTable 1. Estimated shell parameters for both
microbubble populations
Microbubble type Stiffness, Sp (N/m) Friction, Sf (10
26 kg/s)
Bare 0.72 6 0.01 0.37 6 0.05
Liposome-loaded 0.78 6 0.05 0.74 6 0.01within the chamber walls. A waveform generator
(33250A, Agilent Technologies, Cheshire, UK) was pro-
grammed with a 10-ms pre-distorted chirp pulse (3–
8 MHz) (McLaughlan et al. 2013) that accounted for
the response of the broadband transducer (V310,
Olympus Industrial, Essex, UK) to provide a root mean
square (RMS) peak negative pressure of 100 kPa , when
driven by a power amplifier (A150, Electronics & Innova-
tion, Rochester, NY, USA). This pressure level was cho-
sen in an effort to operate in the linear regime of
Fig. 5. Scattered acoustic spectra for (a) 50-, (b) 100-, (c) 150- and (d) 200-kPa tone bursts at 4 MHz, for both micro-
bubble populations.
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Fig. 6. Averaged peak scattered pressures for subharmonic,
fundamental and second harmonic components. Error bars
represent the standard deviations of five repeat measurements.
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distorted chirp it was the maximum achievable pressure
level over the frequency range studied.A 0.2-mm needle hydrophone (Precision Acoustics,
Dorset, UK) was used to calibrate the output RMS pres-
sure of the transducer, and a 1.0-mm needle hydrophone
was used to measure the chirp pulses after propagating
through the interaction chamber. For each sample, 500
measurements were acquired using an oscilloscope
(WaveSurfer 104Xs, Teledyne LeCroy, Berkshire, UK)
and downloaded to a computer for post-processing, which
was repeated five times for water only and bare and
liposome-loaded microbubbles. Each sequence of 500
measurements was then averaged in the frequency
domain and the effect of liposome loading on the shell pa-
rameters of a microbubble population was estimated by
fitting the frequency-dependent attenuation curves with
theoretical predictions (de Jong et al. 1992; Faez et al.
2011; Goertz et al. 2007; Hoff et al. 2000; Raymond
et al. 2014).
Acoustic detection and microbubble destruction
Figure 2(b) is a diagram of the experimental setup
used to measure the acoustic scatter from populations
of bare and liposome-loaded microbubbles. The appa-
ratus used was the same as outlined in the previous sec-
tion. However, for this study, the 1.0-mm hydrophone
was placed perpendicular to the propagation of the ultra-
sound wave to detect the 90 scatter from the microbub-
ble populations when exposed to a 10-ms 4-MHz tone
burst at peak negative pressures of 50 to 300 kPa. The mi-
crobubble population in the chamber was replaced after
each measurement at a given pressure level. In addition,
a 40-dB pre-amplifier (5077PR, Olympus Industrial)
was placed between the hydrophone and oscilloscope.
A direct comparison of the destruction threshold for
bare and liposome-loaded microbubbles was performed
using 2-MHz tone bursts generated by a broadband trans-
ducer (V323, Olympus Industrial), as illustrated in
Figure 3, to establish if liposome loading affects this. A
2-MHz transducer was used for these measurements to
maximise the available mechanical index (MI) to achieve
microbubble destruction, from the electronic drive sys-
tem illustrated in Figure 2. In an effort to minimise effects
from primary and secondary radiation forces (Dayton
et al. 1997; Doinikov and Zavtrak 1996), 10-ms
ultrasound exposures with a low 10-Hz pulse repetition
frequency were used to expose a low concentration
(1 3 105 microbubbles/mL) of microbubbles for 1 s in
a flow cell (m-Slide VI 0.4, Ibidi, Martinsried,
Germany). The transducer was aligned at 45 to the
flow chamber to minimise standing waves. Bright-field
microscopy images were taken before and after the ultra-
sound exposure using an inverted microscope (Eclipse Ti-
U, Nikon UK, Surrey, UK). MATLAB (The MathWorks,
Natick, MA, USA) was used for image analysis to iden-
tify the loss in the microbubble population caused by
Fig. 7. Reduction in microbubble populations through single ultrasound exposures at 2 MHz. Error bars represent stan-
dard deviations of five repeat measurements.
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tive pressures, or MIs (Apfel and Holland 1991; Church
2005). The MI values stated were calculated using the
method that incorporated the effect of pulse duration on
this parameter (Church 2005).RESULTS
Figure 4(a, b) illustrates the attenuation (dB/cm) for
these two microbubble populations measured over the
range 3–8MHz. These datawere used to estimate the shell
parameters of bare and liposome-loaded microbubbles in
Table 1, which reveals that the shell stiffness values are
equivalent and only the shell friction of the loaded micro-
bubbles exhibits a significant increase over that of the bare
microbubbles. In Figure 4(c), the calculated resonant fre-
quency is plotted as a function of equilibrium radius. For
small-amplitude oscillations (Brennen 1995), the reso-
nant frequency, ur, of an encapsulated microbubble that
incorporates the effects of both stiffness and viscous
damping of the shell (Morgan et al. 2000) is given by
u2r 5u
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where R0 is the equilibrium radius of the microbubble
(0.25–5 mm), r is the liquid density (998 kg/m3), g is
the polytropic gas index (1.07), P0 is the hydrostatic pres-
sure (101 kPa), s is the surface tension at the liquid–gas
interface (0.0728 N/m) and m is the liquid viscosity
(0.001 Pa$s). The shell parameters for stiffness and fric-
tion are from the parameters for loaded and bare micro-
bubbles in Table 1.The averaged scattered acoustic pressures from
500 repeat pulses in both microbubble populations for
peak negative pressures of 50–200 kPa are illustrated
in Figure 5. These values are with respect to measure-
ment taken when the chamber was filled with just
filtered and de-ionised water. For both microbubble
types and all acoustic pressure levels, fundamental
and second harmonic components were present, the
amplitude of which increases for increasing acoustic
drive pressures. For liposome-loaded microbubbles a
subharmonic component is present for all pressure
levels that is present only at 200 kPa for the bare micro-
bubble population.
Figure 6 gives the averaged peak components of
subharmonic, fundamental and second harmonic emis-
sions detected from both microbubble populations. For
liposome-loaded microbubbles, subharmonic emissions
are present for all excitation pressures. However, for
bare microbubbles, subharmonic emissions are present
only beyond 200 kPa. The fundamental peak for bare mi-
crobubbles is higher for all pressures used. Second har-
monic emissions are detected for both microbubble
populations for all exposure pressures.
The destruction of both microbubbles populations in
response to a single ultrasound exposure at 2 MHz over a
MI range of 0–0.4 is illustrated in Figure 7. For an MI
greater than 0.4 (570 kPa), 80% of both populations
were destroyed.DISCUSSION
For drug-loaded microbubbles to be realised as ther-
apeutic agents, it is important that their response under ul-
trasound exposure be investigated. In this study, a number
of complementary characterisation techniques were per-
formed on microbubbles that were generated using a mi-
crofluidic manufacturing process (Peyman et al. 2012). In
all cases a direct comparison between liposome-loaded
and bare microbubbles was made such that the shell
354 Ultrasound in Medicine and Biology Volume 43, Number 1, 2017composition, gas core and mean diameter were
equivalent.
The average shell stiffness and friction of the micro-
bubble populations were measured using acoustic attenu-
ation methods routinely used for the characterisation of
ultrasound contrast agents. This indicated that the shell
stiffness values of these microfluidic generated micro-
bubbles were not affected by the attachment of liposomes
and were consistent with those values previously reported
(Peyman et al. 2012). However, these values were slightly
lower than those of the commercial agents SonoVue and
Definity (Faez et al. 2011). The shell friction for
liposome-loaded microbubbles doubled, which is consis-
tent with observed measurements through high speed
photography (Luan et al. 2012). In their study, Luan
et al. proposed that the increased shell friction, or viscos-
ity, was due predominately to the interactions between li-
posomes during microbubble oscillations. It was also
observed that liposome-loaded microbubbles exhibited
‘‘expansion-only’’ behaviour at acoustic pressures below
30 kPa, whereas this type of behavior, where a microbub-
ble would undergo very little or no compression, was pre-
viously observed at high acoustic pressures (Emmer et al.
2007). If it is assumed that the liposomes form a uniform
closely packed layer around the microbubble (Geers et al.
2011), then the equilibrium radius of the bubble R0 would
be effectively equivalent or close to the buckling radius
Rb (Marmottant et al. 2005). This enforced buckled state
would then lead to minimal compression in the microbub-
ble, which would result in expansion-only behaviour
occurring at low acoustic pressures in liposome-loaded
microbubbles when compared with bare microbubbles.
Thus, the presence of liposomes causes a discontinuity
in the shell of the microbubble, which has been proposed
as a cause of reduced subharmonic threshold (Prosperetti
2013), and is the likely cause of the observed decrease in
the subharmonic threshold in this study, as illustrated by
the acoustic spectra in Figure 5. A similar effect has been
simulated with the introduction of gold nanoparticles into
the shell of a microbubble, thus restricting its ability to
compress (Stride et al. 2008). The average subharmonic
peak scattered pressure illustrated in Figure 6 indicates
that at pressures $200 kPa, both microbubble types ex-
ceeded the subharmonic threshold and bare microbubbles
had an increased amplitude beyond this level. The extra
damping, caused by an increased shell friction for the
loaded bubbles, is the likely reason for this difference.
Thus, once the subharmonic threshold for the bare micro-
bubbles was exceeded, the amplitude of these detected
emissions was generally higher (Fig. 6) than that for the
equivalent liposome-loaded microbubbles.
A number of release mechanisms for drug-loaded
microbubbles are possible (Klibanov et al. 2010;
Kooiman et al. 2014; Meijering et al. 2009); however,for targeted liposome-loaded microbubbles (Peyman
et al. 2012), the release mechanism will likely be micro-
bubble destruction. In the absence of sonoporation, the
drug-loaded liposomes would then deliver their therapeu-
tic payload to the targeted cell population through endo-
cytosis (Torchilin 2005). To assess if attaching liposomes
to the shells of these microfluidic generated microbubbles
affects their destruction threshold, a microscopy-based
technique for assessing this was implemented (Fig. 3),
and it was found that there was no difference between
the destruction thresholds of these bare and liposome-
loaded microbubbles (Fig. 7). Molecular-targeted thera-
peutic microbubbles hold significant promise for the
identification and treatment of diseases, such as cancer
(Ibsen et al. 2013). Nevertheless, for contrast-enhanced
ultrasound imaging, subharmonic emissions from micro-
bubbles remain the only uniquely identifiable signal and
would thus be most suitable for molecular imaging
applications.CONCLUSIONS
In this study, acoustic characterisation of microflui-
dic manufactured microbubble populations, which were
either bare or liposome loaded, was performed to assess
the effect that addition of a therapeutic payload may
have on their acoustic response. It was found that lipo-
some loading had a minimal effect on microbubble shell
stiffness and their acoustic destruction threshold. An in-
crease in shell friction was observed for the liposome-
loaded microbubble population. The acoustic pressure
threshold for the production of subharmonic emissions
was significantly lower for the liposome-loaded micro-
bubbles than equivalent bare microbubbles. Attachment
of a therapeutic payload to a microbubbles via liposome
loading will improve their ability to perform molecular
imaging using subharmonic emissions, and combined
with a single-step microfluidic manufacturing process,
it could lead to therapeutic microbubbles making an
important contribution to the identification and treatment
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